Food and Drug Administration
Circulatory System Devices Panel
October 22, 2002
Briefing Information
P020026, CYPHER™ Sirolimus-Eluting Coronary Stent System
Disclaimer
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Summary of Safety and Effectiveness Based on PMA (PDF) (Word)
Understanding Coronary Artery Disease, Cardiac Catheterization, and Treatment Options, A Guide for Patients (PDF) (Word)